AU511331B2 - Vaccines containing both ribosome and saccharide microorganism cell fractions - Google Patents

Vaccines containing both ribosome and saccharide microorganism cell fractions

Info

Publication number
AU511331B2
AU511331B2 AU27538/77A AU2753877A AU511331B2 AU 511331 B2 AU511331 B2 AU 511331B2 AU 27538/77 A AU27538/77 A AU 27538/77A AU 2753877 A AU2753877 A AU 2753877A AU 511331 B2 AU511331 B2 AU 511331B2
Authority
AU
Australia
Prior art keywords
ribosome
saccharide
cell fractions
vaccines containing
microorganism cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU27538/77A
Other languages
English (en)
Other versions
AU2753877A (en
Inventor
L. D. Cormier G. Pinel A. M and Durand J D'Hinterland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pf Medicament SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of AU2753877A publication Critical patent/AU2753877A/en
Application granted granted Critical
Publication of AU511331B2 publication Critical patent/AU511331B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU27538/77A 1976-08-06 1977-08-02 Vaccines containing both ribosome and saccharide microorganism cell fractions Expired AU511331B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FRFR7624124 1976-08-06
FR7624124A FR2360314A2 (fr) 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales

Publications (2)

Publication Number Publication Date
AU2753877A AU2753877A (en) 1979-02-08
AU511331B2 true AU511331B2 (en) 1980-08-14

Family

ID=9176646

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27538/77A Expired AU511331B2 (en) 1976-08-06 1977-08-02 Vaccines containing both ribosome and saccharide microorganism cell fractions

Country Status (9)

Country Link
JP (1) JPS5320418A (ja)
AU (1) AU511331B2 (ja)
BE (1) BE857014R (ja)
CA (1) CA1087093A (ja)
DE (1) DE2735411C2 (ja)
ES (1) ES461415A2 (ja)
FR (1) FR2360314A2 (ja)
GB (1) GB1590144A (ja)
ZA (1) ZA774733B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346074A (en) * 1978-08-24 1982-08-24 National Research Development Corp. Pasteurellosis vaccines
JPS55106066U (ja) * 1979-01-19 1980-07-24
JPS639754Y2 (ja) * 1979-01-25 1988-03-23
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
JPS58191628A (ja) * 1982-05-04 1983-11-08 Aisin Seiki Co Ltd 車輌ル−フパネル開閉装置
JPS626614A (ja) * 1985-07-03 1987-01-13 株式会社チノー 温室の天窓制御装置
JPS62104526A (ja) * 1985-10-30 1987-05-15 株式会社チノー 温室の制御装置
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
GB2370839A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex useful for disease control

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142528A (en) * 1975-05-19 1976-12-08 Fabre Sa Pierre Production of vaccine based on antigenic libosome fractionation

Also Published As

Publication number Publication date
BE857014R (fr) 1978-01-20
DE2735411C2 (de) 1982-07-29
ZA774733B (en) 1978-07-26
ES461415A2 (es) 1978-07-16
FR2360314A2 (fr) 1978-03-03
CA1087093A (en) 1980-10-07
DE2735411A1 (de) 1978-02-09
AU2753877A (en) 1979-02-08
JPS5320418A (en) 1978-02-24
GB1590144A (en) 1981-05-28
FR2360314B2 (ja) 1980-04-25

Similar Documents

Publication Publication Date Title
AU518958B2 (en) Air depolarzed cell
AU511331B2 (en) Vaccines containing both ribosome and saccharide microorganism cell fractions
AU514849B2 (en) Composition and process
AU512626B2 (en) 4-Hydroxyphenylalkanolamine derivatives and preparation thereof
AU535400B2 (en) Wirebroadcast and viewphone
AU508398B2 (en) Cell culture microcarriers
AU535880B2 (en) 5h-furanone-2 and 3h-dihydrofuranone-2 derivatives
AU507632B2 (en) Antibiotic 7-0-Alkylnogarnols
AU508896B2 (en) Metaaminophenols and dyes containing same
AU538551B2 (en) Static memory cell
AU5822380A (en) Easel
IL54898A (en) Stabilized thymidine phosphorylase preparations and culture media comprising them
SU621845A1 (ru) Воздухоопорное сооружение
SU584319A2 (ru) Устройство дл моделировани атмосферных влений
AU514594B2 (en) Antibiotic substance
AU514242B2 (en) Borosilicate and germania-silicate material
AU514519B2 (en) Antibiotic bl580
AU518500B2 (en) Anhydro-sugars and pharmaceuticals
AU516174B2 (en) D-homosteroids and pharmaceuticals
AU549876B2 (en) Dihydrocyclosporin d and isocyclosporin d
AU514489B2 (en) Lithium-chlorine cell
AU520966B2 (en) N-phosphonoacetyl-l-aspartic and derivatives
AU494625B2 (en) Improvements in or relating tothe supporting of ducting
AU5628280A (en) 1-epi-fortimicin and derivatives
AU513176B2 (en) Combined document and envelope